AVE-8134

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAVE-8134
Drug Alias NameAVE-8134
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2Heart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiGenfit Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiGenfit Corp
Active IndicationsN/A
Inactive IndicationsLipid Metabolism DisordersDiabetes Mellitus, Type 2Heart Failure

Other Information

ATC CodeN/A
Related LinksN/A